Highway Pharmaceuticals is a clinical-stage biotechnology company focused on reformulating and repositioning effective but dangerous generics to make safer, extended-release versions of those drugs.
Our initial therapeutic is an extended-release formulation of cyclosporine that’s also safer and easier to use than the existing formulation. We’re exploring both human and veterinary uses for this therapeutic.
Our advisors are:
Clinical: Marcus Maurer, MD, Director of the Allergy-Centrum-Charité at the Charité University Medicine in Berlin, the largest international center devoted to allergic diseases.
Patent: Brenda Jarrell, PhD, JD, chair of Choate’s Intellectual Property and Life Sciences Group.
Scientific: Ethan Lerner, MD, PhD, associate professor of itch at Harvard Medical School.
The President of the company is Trevor Klee, and we are based in Boston, Massachusetts.
If you’re interested, please get in touch.